[How I treat newly diagnosed chronic myeloid leukemia in chronic phase]
- PMID: 27535851
- PMCID: PMC7365010
- DOI: 10.3760/cma.j.issn.0253-2727.2016.07.001
[How I treat newly diagnosed chronic myeloid leukemia in chronic phase]
Similar articles
-
Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia.Clin Ther. 2012 Feb;34(2):272-81. doi: 10.1016/j.clinthera.2012.01.009. Epub 2012 Jan 27. Clin Ther. 2012. PMID: 22285209 Review.
-
Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and Kantarjian H, Shah NP, Hochhaus A, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010;362:2260-70.Expert Opin Pharmacother. 2011 Jan;12(1):157-63. doi: 10.1517/14656566.2011.534780. Epub 2010 Nov 26. Expert Opin Pharmacother. 2011. PMID: 21108601
-
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.Future Oncol. 2022 Dec;18(38):4161-4170. doi: 10.2217/fon-2022-0923. Epub 2022 Dec 16. Future Oncol. 2022. PMID: 36524980
-
Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase.Curr Opin Hematol. 2007 Mar;14(2):138-44. doi: 10.1097/MOH.0b013e32801684a3. Curr Opin Hematol. 2007. PMID: 17255791 Review.
-
Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients.Front Oncol. 2024 Jun 24;14:1418417. doi: 10.3389/fonc.2024.1418417. eCollection 2024. Front Oncol. 2024. PMID: 38978732 Free PMC article.
References
-
- 全国白血病与再生障碍性贫血流行病学调查协作组. 全国白血病发病情况调查[J] 中国医学科学院学报. 1992;14(1):12–18. - PubMed
-
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia version 1. 2016. http://www.nccn.org/professionals/physician_gls/pdf/cml. Accessed 2 May 2016. - PubMed